Literature DB >> 19476335

Metabonomic evaluation of melamine-induced acute renal toxicity in rats.

Guoxiang Xie1, Xiaojiao Zheng, Xin Qi, Yu Cao, Yi Chi, Mingming Su, Yan Ni, Yunping Qiu, Yumin Liu, Houkai Li, Aihua Zhao, Wei Jia.   

Abstract

The recent outbreak of renal failure in infants in China has been determined to be caused by melamine (Mel) and derivatives adulterated in the food. A metabonomic study was performed to evaluate the global biochemical alteration triggered by Mel ingestion in parallel with the acute renal toxicity in rats. Mel at 600, 300, and 100 mg/kg, cyanuric acid (Cya) at 100 mg/kg, and mixture of Mel and Cya (50 mg/kg each) were administered in five groups of Wistar rats, respectively, via oral gavage for 15 days. Urinary metabonomic profiles indicated that Mel perturbed urinary metabolism in a dose-dependent manner, with high-dose group showing the most significant impact. Metabonomic variations also suggest that the toxicity of low-dose (50 mg/kg) Mel was greatly elevated by the presence of Cya (at 50 mg/kg), which was able to induce a significant metabolic alteration to a level equivalent to that of 600 mg/kg Mel. Histological examination and serum biochemical analysis also indicated that the low-dose Mel-Cya mixture and high-dose Mel group resulted in the greatest renal toxicity. The high-dose Mel and low-dose Mel-Cya resulted in disrupted amino acid metabolism including tryptophan, polyamine, and tyrosine metabolism, and altered TCA and gut microflora structure.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19476335     DOI: 10.1021/pr900333h

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  18 in total

1.  Dose-response assessment of nephrotoxicity from a 7-day combined exposure to melamine and cyanuric acid in F344 rats.

Authors:  Cristina C Jacob; Renate Reimschuessel; Linda S Von Tungeln; Greg R Olson; Alan R Warbritton; David G Hattan; Frederick A Beland; Gonçalo Gamboa da Costa
Journal:  Toxicol Sci       Date:  2010-10-28       Impact factor: 4.849

Review 2.  A Brief Review of Neurotoxicity Induced by Melamine.

Authors:  Lei An; Wei Sun
Journal:  Neurotox Res       Date:  2017-04-13       Impact factor: 3.911

Review 3.  Metabolomics in human type 2 diabetes research.

Authors:  Jingyi Lu; Guoxiang Xie; Weiping Jia; Wei Jia
Journal:  Front Med       Date:  2013-02-02       Impact factor: 4.592

4.  Antagonistic and Biocontrol Potential of Trichoderma asperellum ZJSX5003 Against the Maize Stalk Rot Pathogen Fusarium graminearum.

Authors:  Yaqian Li; Ruiyan Sun; Jia Yu; Kandasamy Saravanakumar; Jie Chen
Journal:  Indian J Microbiol       Date:  2016-04-18       Impact factor: 2.461

Review 5.  Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics.

Authors:  Rachel N Carmody; Peter J Turnbaugh
Journal:  J Clin Invest       Date:  2014-08-08       Impact factor: 14.808

Review 6.  Isolation and analysis of ginseng: advances and challenges.

Authors:  Lian-Wen Qi; Chong-Zhi Wang; Chun-Su Yuan
Journal:  Nat Prod Rep       Date:  2011-01-24       Impact factor: 13.423

Review 7.  Metabolomics in the study of kidney diseases.

Authors:  Robert H Weiss; Kyoungmi Kim
Journal:  Nat Rev Nephrol       Date:  2011-10-25       Impact factor: 28.314

8.  The true stone composition and abnormality of urinary metabolic lithogenic factors of rats fed diets containing melamine.

Authors:  Xiaoming Cong; Xiaojian Gu; Yan Xu; Xizhao Sun; Luming Shen
Journal:  Urolithiasis       Date:  2013-11-28       Impact factor: 3.436

Review 9.  Calorie restriction and its impact on gut microbial composition and global metabolism.

Authors:  Xiaojiao Zheng; Shouli Wang; Wei Jia
Journal:  Front Med       Date:  2018-11-16       Impact factor: 4.592

10.  Metabolic profiling provides a system understanding of hypothyroidism in rats and its application.

Authors:  Si Wu; Guangguo Tan; Xin Dong; Zhenyu Zhu; Wuhong Li; Ziyang Lou; Yifeng Chai
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.